Factors Influencing Hepatitis C Virus Sero-prevalence among Blood Donors in North West Pakistan

被引:0
作者
Muhammad Naeem Khattak
Saeed Akhtar
Sadia Mahmud
Tariq Mahmood Roshan
机构
[1] Unit of Epidemiology and Biostatistics,Department of Community Medicine
[2] Universiti Sains Malaysia,Department of Medicine
[3] Faculty of Medicine,Division of Epidemiology and Biostatistics, Department of Community Health Sciences
[4] Health Sciences Center,Department of Haematology
[5] Aga Khan Universiti,undefined
[6] School of Medical Sciences,undefined
[7] Universiti Sains Malaysia,undefined
来源
Journal of Public Health Policy | 2008年 / 29卷
关键词
hepatitis C; blood donors; blood transfusion; public health;
D O I
暂无
中图分类号
学科分类号
摘要
Hepatitis C virus infection is a major health problem worldwide. The current study estimated seroprevalence of Hepatitis C virus (HCV) and evaluated associated factors among volunteer blood donors of the Northwest Frontier Province (NWFP), Pakistan. Of 1,131 volunteer blood donors enrolled, 46 (4.1%) were positive for anti-HCV antibodies. Multivariate logistic regression analysis revealed that positive donors were more likely to be 27–32 years old or >32 years old, have had 1–2 injections or >2 injections in the past year, or 1–5 intravenous (IV) drips or >5 I/V drips in the past 5 years. Positive donors had a family history of jaundice and were more likely to have been shaved (facial and armpit) by barbers. There was high prevalence of anti-HCV antibodies among blood donors of the NWFP. Public awareness programs should target the identified risk factors to prevent HCV transmission. We highlight the weakness of the health care system for blood donation, as it does not offer any record management for donors.
引用
收藏
页码:207 / 225
页数:18
相关论文
共 179 条
[1]  
Alter MJ(1999)The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 341 556-562
[2]  
Kruszon-Moran D(1997)Natural history of hepatitis C Hepatology 26 21-28
[3]  
Nainan OV(1996)The long-term pathological evolution of chronic hepatitis C Hepatology 23 1334-1340
[4]  
McQuillan GM(1997)Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients Gastroenterology 112 463-472
[5]  
Gao F(1998)Determinants of outcome of compensated hepatitis C virus-related cirrhosis Hepatology 27 1435-1440
[6]  
Moyer LA(1989)Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis Lancet 2 1004-1006
[7]  
Seef L(1991)Hepatitis C in patients undergoing liver transplantation Ann Intern Med 114 282-284
[8]  
Yano M(1996)The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellular carcinoma Epidemiol Infect 117 327-332
[9]  
Kumada H(1990)Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV) J Hepatol 10 69-76
[10]  
Kage M(1999)Risk factors for acquisition of hepatitis C virus infection in blood donors: results of a case-control study Gastroenterology 116 893-899